| # | Drug | Count |
|---|---|---|
| 0 | LEFLUNOMIDE | 27 |
| 1 | METHOTREXATE | 22 |
| 2 | METHOTREXATE SODIUM | 22 |
| 3 | PREDNISONE | 22 |
| 4 | ADALIMUMAB | 15 |
| 5 | HYDROXYCHLOROQUINE | 15 |
| 6 | ETANERCEPT | 13 |
| 7 | ERGOCALCIFEROL | 12 |
| 8 | NAPROXEN | 11 |
| 9 | NAPROXEN SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAL TAR | 3 | 0.0038 |
| 1 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 2 | BRODALUMAB | 3 | 0.0015 |
| 3 | CALCIUM CHLORIDE INJECTION | 3 | 0.0010 |
| 4 | GOLIMUMAB | 7 | 0.0006 |
| 5 | BETAMETHASONE DIPROPIONATE | 3 | 0.0004 |
| 6 | BETAMETHASONE VALERATE FOAM | 2 | 0.0004 |
| 7 | ERGOCALCIFEROL | 12 | 0.0004 |
| 8 | DIFLUPREDNATE | 1 | 0.0003 |
| 9 | LEFLUNOMIDE | 27 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 1 | Antirheumatic Agent [EPC] | 27 |
| 2 | Corticosteroid [EPC] | 22 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 5 | Provitamin D2 Compound [EPC] | 12 |
| 6 | Thiazide Diuretic [EPC] | 9 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| 8 | Interleukin-23 Antagonist [EPC] | 7 |
| 9 | Vitamin C [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 1 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 2 | Antirheumatic Agent [EPC] | 27 | 0.0003 |
| 3 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 5 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Interleukin-23 Antagonist [EPC] | 7 | 0.0001 |
| 7 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 22 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 9 | 0.0000 |